Alexion Pharma Canada
2 meetings with public office holders, Jul 14, 2026 to Jul 24, 2026.
13 meetings on record since 2018, their first on record.
What they lobby about
- Budget2
- Health2
- Industry2
- Economic Development1
- Federal-Provincial Relations1
- Intellectual Property1
- Research and Development1
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Conservative1 met · 1 meeting
Not in Arena's member list1 met · 1 meeting
- Ritu Banerjee
House of Commons (1) · Innovation, Science and Economic Development Canada (ISED) (1)
In their own words
- Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
- Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.